SNCA and Parkinson disease: The correlation between expressed chaperone and co-chaperone transcripts and α-synuclein in humans are also supportive of a role for the chaperome in α-synuclein function in multiple brain regions and ages, especially considering that other members of the machinery also present increased expression in Parkinson’s disease brains [19, 26, 106, 121].